{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T20:17:47Z","timestamp":1787948267043,"version":"build-2784847793"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018736","name":"Kaken Pharmaceutical Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["25K11893"],"award-info":[{"award-number":["25K11893"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23K19638"],"award-info":[{"award-number":["23K19638"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["23K08054"],"award-info":[{"award-number":["23K08054"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpedsurg.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Surgery"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jpedsurg.2026.163374","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:22:32Z","timestamp":1786663352000},"page":"163374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A novel immunocompetent mouse model of neuroblastoma bone marrow metastasis as a therapeutic target for mesenchymal stem cell-based immunotherapy"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3662-4029","authenticated-orcid":false,"given":"Atsuro","family":"Takimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maho","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyokazu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonori","family":"Kawakubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehisa","family":"Fumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsunao","family":"Kishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osam","family":"Mazda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpedsurg.2026.163374_bib1","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1158\/1078-0432.CCR-20-3909","article-title":"Long-term follow-up of a phase III study of ch14.18 (dinutuximab) plus cytokine immunotherapy in children with high-risk neuroblastoma: COG study ANBL0032","volume":"27","author":"Yu","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib2","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1200\/JCO.21.00278","article-title":"Revised neuroblastoma risk classification system: a report from the children's oncology group","volume":"39","author":"Irwin","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib3","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10147-018-1281-8","article-title":"Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan childhood cancer group neuroblastoma committee (JNBSG)","volume":"23","author":"Hishiki","year":"2018","journal-title":"Int J Clin Oncol"},{"issue":"6","key":"10.1016\/j.jpedsurg.2026.163374_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.30976","article-title":"A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: the Japan children's cancer group neuroblastoma committee trial JN-H-11","volume":"71","author":"Yoneda","year":"2024","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib5","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.jpedsurg.2016.09.041","article-title":"Tumor-homing effect of human mesenchymal stem cells in a TH-MYCN mouse model of neuroblastoma","volume":"51","author":"Kimura","year":"2016","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib6","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1016\/j.jpedsurg.2019.08.023","article-title":"Novel mesenchymal stem cell delivery system as targeted therapy against neuroblastoma using the TH-MYCN mouse model","volume":"54","author":"Maniwa","year":"2019","journal-title":"J Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib7","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.21873\/anticanres.16409","article-title":"Development of anti-GD2 antibody-producing mesenchymal stem cells as cellular immunotherapy","volume":"43","author":"Iguchi","year":"2023","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00383-022-05310-z","article-title":"Development of minimally invasive cancer immunotherapy using anti-disialoganglioside GD2 antibody-producing mesenchymal stem cells for a neuroblastoma mouse model","volume":"39","author":"Kambe","year":"2023","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib9","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jconrel.2020.10.037","article-title":"Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy","volume":"329","author":"Takayama","year":"2021","journal-title":"J Contr Release"},{"issue":"6","key":"10.1016\/j.jpedsurg.2026.163374_bib10","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1158\/0008-5472.CAN-24-1507","article-title":"Comparative single-cell transcriptomics of human neuroblastoma and preclinical models reveals conservation of an adrenergic cell state","volume":"85","author":"Embaie","year":"2025","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib11","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00383-019-04568-0","article-title":"Enhanced metastatic growth after local tumor resection in the presence of synchronous metastasis in a mouse allograft model of neuroblastoma","volume":"35","author":"Inoue","year":"2019","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib12","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1093\/emboj\/16.11.2985","article-title":"Targeted expression of MYCN causes neuroblastoma in transgenic mice","volume":"16","author":"Weiss","year":"1997","journal-title":"EMBO J"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib13","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1158\/0008-5472.CAN-16-3144","article-title":"PRC2-mediated transcriptomic alterations at the embryonic stage govern tumorigenesis and clinical outcome in MYCN-driven neuroblastoma","volume":"77","author":"Tsubota","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib14","article-title":"A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model","volume":"9","author":"Cao","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib15","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1158\/0008-5472.CAN-10-3524","article-title":"The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma","volume":"71","author":"Huang","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib16","first-page":"19","article-title":"Description of a new xenograft model of metastatic neuroblastoma using NOD\/SCID\/Il2rg null (NSG) mice","volume":"26","author":"Sartelet","year":"2012","journal-title":"In Vivo (Athens)"},{"issue":"20","key":"10.1016\/j.jpedsurg.2026.163374_bib17","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.1631","article-title":"Immune cell isolation from mouse femur bone marrow","volume":"5","author":"Liu","year":"2015","journal-title":"Bio Protoc"},{"issue":"2","key":"10.1016\/j.jpedsurg.2026.163374_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3390\/cancers12020385","article-title":"Modeling spontaneous bone metastasis formation of solid human tumor xenografts in mice","volume":"12","author":"Labitzky","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.jpedsurg.2026.163374_bib19","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1158\/0008-5472.CAN-12-2681","article-title":"TH-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis","volume":"73","author":"Teitz","year":"2013","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.jpedsurg.2026.163374_bib20","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1158\/0008-5472.CAN-18-2759","article-title":"In vivo modeling of chemoresistant neuroblastoma provides new insights into chemorefractory disease and metastasis","volume":"79","author":"Yogev","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/laban0511-155","article-title":"Retro-orbital injections in mice","volume":"40","author":"Yardeni","year":"2011","journal-title":"Lab Anim"},{"issue":"2","key":"10.1016\/j.jpedsurg.2026.163374_bib22","doi-asserted-by":"crossref","first-page":"209","DOI":"10.4103\/jiaps.JIAPS_375_20","article-title":"Pediatric neuroblastoma: impact of nutritional status on complications and outcomes","volume":"27","author":"Nandan","year":"2022","journal-title":"J Indian Assoc Pediatr Surg"},{"key":"10.1016\/j.jpedsurg.2026.163374_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jss.2024.03.032","article-title":"Differential RNA expression between metastatic and primary neuroblastoma cells","volume":"298","author":"Lee","year":"2024","journal-title":"J Surg Res"},{"issue":"8","key":"10.1016\/j.jpedsurg.2026.163374_bib24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1248\/bpb.b21-00276","article-title":"Development of advanced cell-based therapy by regulating cell\u2013cell interactions","volume":"44","author":"Kusamori","year":"2021","journal-title":"Biol Pharm Bull"},{"issue":"1","key":"10.1016\/j.jpedsurg.2026.163374_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpedsurg.2024.161954","article-title":"A comparison of in vivo tumor-homing abilities of placental-derived and bone marrow-derived mesenchymal stromal cells in high-risk neuroblastoma","volume":"60","author":"Doyle","year":"2025","journal-title":"J Pediatr Surg"},{"issue":"8","key":"10.1016\/j.jpedsurg.2026.163374_bib26","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.jpedsurg.2024.02.014","article-title":"Proliferative effects of mesenchymal stromal cells on neuroblastoma cell lines: are they tumor promoting or tumor inhibiting?","volume":"59","author":"Doyle","year":"2024","journal-title":"J Pediatr Surg"},{"issue":"2","key":"10.1016\/j.jpedsurg.2026.163374_bib27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1089\/scd.2020.0142","article-title":"Mesenchymal stromal cells in neuroblastoma: exploring crosstalk and therapeutic implications","volume":"30","author":"Hochheuser","year":"2021","journal-title":"Stem Cell Dev"}],"container-title":["Journal of Pediatric Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346826004562?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022346826004562?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:41:14Z","timestamp":1787946074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022346826004562"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":27,"alternative-id":["S0022346826004562"],"URL":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2026.163374","relation":{},"ISSN":["0022-3468"],"issn-type":[{"value":"0022-3468","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel immunocompetent mouse model of neuroblastoma bone marrow metastasis as a therapeutic target for mesenchymal stem cell-based immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpedsurg.2026.163374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"163374"}}